Operating Activities: | |
Net income | 34.82M |
Adjustments to reconcile net income to net cash provided by operating activities: | |
Depreciation, amortization and accretion | 73.2M |
Stock-based compensation | 23.89M |
(Decrease) increase in allowance for returns - net of inventory in transit | -14.96M |
Loss on disposal of assets | -9.87M |
Impairment losses | 2.21M |
Equity in loss (income) of joint venture | |
Distribution from joint venture | |
Decrease in allowance for doubtful accounts | |
Excess tax benefits from stock-based compensation | -5K |
Deferred income taxes and other | |
Changes in operating assets and liabilities: | |
Accounts receivable | 74.71M |
Inventories | -76.87M |
Prepaid expenses and other current assets | 17.64M |
Accounts payable | -16.89M |
Accrued expenses | -38.57M |
Income taxes payable | -9.26M |
Net cash provided by operating activities | |
Investing Activities: | |
Additions to property, plant and equipment | -53.52M |
Increase in intangible and other assets | |
Purchase of securities available for sale | |
Sales/maturities of securities available for sale | |
Proceeds from the sale of property, plant and equipment | 44.58M |
Net cash used in investing activities | |
Financing Activities: | |
Acquisition of common stock | -6.45M |
Distribution of noncontrolling interest earnings | -4.54M |
Excess tax benefits from stock-based compensation | 5K |
Borrowings on notes payable | 756M |
Payments on notes payable | -839.63M |
Proceeds from exercise of stock options | 57K |
Net cash used in financing activities | |
Effect of exchange rate changes on cash and cash equivalents | |
Net (decrease) increase in cash and cash equivalents | |
Cash and cash equivalents: | |
Beginning of period | 289.28M |
End of period | 235.95M |